FundedIQ
Biopharma

KymaThera: Funding, Investors & Team (Oct 2026)

KymaThera is an biotech startup that develops precision small-molecule drugs targeting diseases like cancer and fibrosis.

www.kymathera.com LinkedIn San Diego, United States 1-10 employees Founded 2024
Total raised
$80.0M
Rounds
1
Latest
Series B
Oct 2026

KymaThera has raised $80.0M across 1 funding round on record, the most recent a Series B of $80.0M announced in Oct 2026.

That round is above the $7.6M median round size for United States companies tracked on FundedIQ over the last two years.

KymaThera Company Profile and Key Stats

Total funding raised
$80.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series B
$80.0M in Oct 2026
Employees
1-10
reported band
Founded
2024
Headquarters
San Diego, United States
Investors on record
4
4 named below

Latest funding round on record: Oct 2026.

KymaThera Funding Rounds

Date
Round
Amount
Series B
$80.0M

KymaThera Investors

Foresite Capital Venrock Alta Partners J. Wood Capital Advisors

KymaThera Founders and Leadership Team

Name
Role
Contact
Rob Kania
CEO and Co-founder
Locked

Contact details for the KymaThera team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.

Start 14-day free trial →

KymaThera Funding in Context

Segment
Companies
Median round
30,234
$7.6M
4,401
$31M

KymaThera's latest round of $80.0M is above the median round in United States. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like KymaThera in Biopharma and San Diego

Companies Similar to KymaThera

AnaCardio is a clinical stage biopharmaceutical company developing novel drugs to treat heart failure.

Series B $70.8M

Onyx is a research collective building a virtual immune system from longitudinal human immune data.

Undisclosed round $8.0M

Hone creates AI agents that can help run a business, joining a crowded field of services using the technology…

Seed $60.0M

Sonilo provides an AI video-to-music platform that generates synchronized, commercially usable soundtracks…

Seed $11.0M

PlotPicks is an interactive entertainment platform that combines television viewing with prediction-based…

Seed $50k

Negosh operates a data-driven platform and marketplace that connects brand owners with manufacturers and…

Seed $3.1M

Insuraviews provides software for analyzing insurance rate filings with search, analytics, and competitive…

Seed $750k

Thrixel is an AI-powered 3D model generation platform designed to integrate directly with coding agents, AI…

Seed $3.0M

Vye Health is an AI-native healthcare company that provides tools for medical providers to launch and run…

Undisclosed round $16.2M

Park Golf Pitch & Putt is a sports company that focuses on outdoor entertainment with focus on pitch-putt…

Seed $700k

Phinge® Creating Netverse®, Patented App-less, Integrated Technologies & Verifed Platform & AI With…

Convertible Note $100k

Gallatin is developing a logistics system that is tailored to the current requirements and limitations of the…

Series A $50.0M

KymaThera Funding FAQs

What does KymaThera do?

KymaThera is an biotech startup that develops precision small-molecule drugs targeting diseases like cancer and fibrosis.

How much funding has KymaThera raised?

KymaThera has raised $80.0M across 1 round on record. The most recent is a Series B of $80.0M announced in Oct 2026.

When did KymaThera last raise funding?

KymaThera's most recent funding round on record is a Series B of $80.0M, announced in Oct 2026.

Who has invested in KymaThera?

Investors on record for KymaThera include Foresite Capital, Venrock, Alta Partners, J. Wood Capital Advisors.

Who founded KymaThera?

FundedIQ lists Rob Kania (CEO and Co-founder) at KymaThera.

Where is KymaThera headquartered?

KymaThera is based in San Diego, United States.

How many employees does KymaThera have?

KymaThera is in the 1-10 employee band.

When was KymaThera founded?

KymaThera was founded in 2024.

About FundedIQ's KymaThera Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for KymaThera is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.